Argatroban labels and packages: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
Cipla Ltd., India | Cipla Ltd., India | ||
For: | For: | ||
Eagle Pharmaceuticals, Inc. | '''Eagle Pharmaceuticals, Inc.''' | ||
Woodcliff Lake, N.J. 07677 | Woodcliff Lake, N.J. 07677 | ||
| Line 15: | Line 15: | ||
Parsippany, N.J. 07054 | Parsippany, N.J. 07054 | ||
THE MEDICINES COMPANY® | THE '''MEDICINES''' COMPANY® | ||
June 2011 | '''June''' 2011 | ||
Eagle Pharmaceuticals, Inc. | '''Eagle Pharmaceuticals, Inc. | ||
Principal Display Panel – Vial Label | Principal Display Panel – Vial Label | ||
| Line 40: | Line 40: | ||
Single Use Vial | Single Use Vial | ||
Discard Unused Portion | Discard Unused Portion''' | ||
{| | {| | ||
| [[File:Argatroban_14.png|thumb|600px]] | | [[File:Argatroban_14.png|thumb|600px]] | ||
| Line 49: | Line 49: | ||
NDC 42367-203-07 Rx Only | NDC 42367-203-07 Rx Only | ||
Argatroban | '''Argatroban | ||
Injection | Injection | ||
| Line 67: | Line 67: | ||
Discard Unused Portion | Discard Unused Portion | ||
THE MEDICINES COMPANY® | THE MEDICINES COMPANY®''' | ||
{| | {| | ||
| [[File:Argatroban_15.png|thumb|600px]] | | [[File:Argatroban_15.png|thumb|600px]] | ||
| Line 76: | Line 76: | ||
NDC 42367-203-84 Rx Only | NDC 42367-203-84 Rx Only | ||
Argatroban | '''Argatroban | ||
Injection | Injection | ||
| Line 89: | Line 89: | ||
Infusion Only | Infusion Only | ||
THE MEDICINES COMPANY®<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher = | date = | accessdate = }}</ref> | THE MEDICINES COMPANY®'''<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher = | date = | accessdate = }}</ref> | ||
{| | {| | ||
| [[File:Argatroban_16.png|thumb|600px]] | | [[File:Argatroban_16.png|thumb|600px]] | ||
Revision as of 04:15, 5 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]
Labels and Packages
Manufactured by: Cipla Ltd., India For: Eagle Pharmaceuticals, Inc. Woodcliff Lake, N.J. 07677
Marketed by: The Medicines Company Parsippany, N.J. 07054
THE MEDICINES COMPANY®
June 2011 Eagle Pharmaceuticals, Inc.
Principal Display Panel – Vial Label
NDC 42367-203-07 Rx Only
Argatroban
Injection
50 mg per 50 mL
(1 mg per mL)
Do not dilute
prior to administration
For Intravenous Infusion Only
Single Use Vial
Discard Unused Portion
 |
Principal Display Panel – Carton Label
NDC 42367-203-07 Rx Only
Argatroban
Injection
50 mg per 50 mL
(1 mg per mL)
Do not dilute
prior to administration
For Intravenous Infusion Only
Single Use Vial
Discard Unused Portion
THE MEDICINES COMPANY®
 |
Principal Display Panel – Box Label
NDC 42367-203-84 Rx Only
Argatroban
Injection
50 mg per 50 mL
(1 mg per mL)
10 Single Use Vials
For Intravenous Infusion Only
THE MEDICINES COMPANY®[1]
 |
 |
Reference
Adapted from the FDA Package Insert.